Skip to main content

High BMI in Adolescence Linked to Early CKD in Young Adulthood

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 12, 2023.

By Elana Gotkine HealthDay Reporter

MONDAY, Dec. 11, 2023 -- High body mass index (BMI) in late adolescence is associated with early chronic kidney disease (CKD) in young adulthood, according to a study published online Dec. 11 in JAMA Pediatrics.

Avishai M. Tsur, M.D., from the Israel Defense Forces, Medical Corps, in Ramat Gan, and colleagues examined the association between adolescent BMI and early CKD in young adulthood (younger than 45 years). The analysis included 629,168 adolescents (54.5 and 45.5 percent males and females, respectively) aged 16 to 20 years, medically evaluated for mandatory military service. Early CKD was defined as stage 1 to 2 CKD based on moderately or severely increased albuminuria, with an estimated glomerular filtration rate of ≥60 mL/min/1.73 m2.

The researchers found that during a mean follow-up of 13.4 years for males and females, 0.3 percent developed early CKD. The adjusted hazard ratios for CKD were 1.8, 4.0, 6.7, and 9.4 for adolescents with high-normal BMI, overweight, mild obesity, and severe obesity, respectively, among males. The corresponding hazard ratios among females were 1.4, 2.3, 2.7, and 4.3. When the cohort was limited to individuals who were seemingly healthy as adolescents, those surveyed up to 30 years of age, or those free of diabetes and hypertension at the end of follow-up, the results were similar.

"Given the increasing obesity rates among adolescents, our findings are a harbinger of the potentially preventable increasing burden of CKD and subsequent cardiovascular disease," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Text Messages + Financial Incentives Boost Weight Loss at 12 Months

WEDNESDAY, May 15, 2024 -- Among men with obesity, an intervention with text messaging plus financial incentive significantly improves weight loss compared with a control group...

GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription

WEDNESDAY, May 15, 2024 -- Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a...

Four in 10 Adults With Diabetes Report Taking a GLP-1 Receptor Agonist

TUESDAY, May 14, 2024 -- One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.